We are very proud to announce that Greece has officially joined ECRIN-ERIC as a Member country. The hub of the Greek network, GreCRIN, will be hosted at the Centre for Research and Technology, Hellas (CERTH) in Thessaloniki.
ECRIN and the Swiss Clinical Trial Organisation (SCTO) are very pleased to announce that Switzerland officially became an ECRIN-ERIC Member country on 22 May 2023.
ECRIN, together with our Polish national partner, PolCRIN, represented by the Polish Medical Research Agency, organised International Clinical Trial Day (ICTD) 2023. ICTD 2023 was a hybrid event with 700 attendees focusing on Decentralised Clinical Trials: Challenges and Opportunities, and was held in the Hotel Bellotto in the heart of Warsaw where it was live broadcast to our online audience.
A dedicated recap newsletter is coming soon...
Get to know our National Partners
We continue the tour of ECRIN national partners: KKSN aims to strengthen patient oriented academic clinical research.
ICPerMed published a set of recommendations developped with the PERMIT project for optimizing personalised medicine (PM) related clinical research as a brief specifically addressed to policy, funding bodies and regulatory agencies.
This project has received funding from the European Union’s Horizon 2020 programme under grant agreement number N874825.
REMEDi4ALL Factsheet and Drug Repurposing Concierge
To give a short overview of the project, a new factsheet about the REMEDi4ALL project has been released, including among others the Vision, Key Facts & Figures, and the Pilot Projects.
If you have a medicines repurposing project that may require support, the Remedi4All project launched its Repurposing Concierge. Just fill out the form, and start a chat with the team and see how they can help you.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement number N101057442.
eCREAM face-to-face meeting in Maribor
UKC Maribor organised the eCREAM meeting in Maribor Slovenia on the 4th and 5th of April, where all partners exchanged on the ongoing work. As a consortium partner and leader of the WP5-FAIRification and ELSI compliance, ECRIN participated in the meeting and moderated a session on ELSI aspects (ethical, legal and societal issues) within eCREAM.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement number N101057726.
OTHER NEWS
EU-X-CT Initiative
The EU-X-CT initiative has been established to help enable cross-border access to trials for patients when there is no option for them to join a clinical trial in their own country.
In short, EU-X-CT will be reaching out to stakeholders for support in developing constructive answers to three primary questions:
Is cross-border trial participation allowed in a country? (i.e. regulatory & legal aspects)
Who is going to pay for it? (i.e. trial sponsor, healthcare provider, insurance etc.)
How do we bring it about? (i.e. practical implications for patients, study sites, sponsors)
On 13 June RESPINE organises its final workshop in Montpellier (France). The agenda and the registration form are available at the RESPINE website here. For any further information about RESPINE, you can visit the ECRIN website or the RESPINE website.
SRIA for Personalised Medicine
ICPerMed announced the publication of the Strategic Research and Innovation Agenda (SRIA) for Personalised Medicine (PM). This SRIA aims to support a wide range of stakeholders and experts to further develop programs, activities, and research towards PM and care, as well as prevention.
Our Italian partner, ItaCRIN, co-hosted a 2 day workshop on Fairifying sensitive data: technical, legal and practical consideration in the biomedical field. This training event introduced the principles of biological and medical sensitive data and medical applications, access to data resources and data FAIRification. The workshop was co-hosted by Istituto Superiore di Sanità (ISS) and funded by EOSC-Life project.
ICPerMed announced the publication of the Strategic Research and Innovation Agenda (SRIA) for Personalised Medicine (PM). This SRIA aims to support a wide range of stakeholders and experts to further develop programs, activities, and research towards PM and care, as well as prevention.
Our Italian partner, ItaCRIN, co-hosted a 2 day workshop on Fairifying sensitive data: technical, legal and practical consideration in the biomedical field. This training event introduced the principles of biological and medical sensitive data and medical applications, access to data resources and data FAIRification. The workshop was co-hosted by Istituto Superiore di Sanità (ISS) and funded by EOSC-Life project.
